[go: up one dir, main page]

AU3099600A - Pharmaceutical agent - Google Patents

Pharmaceutical agent

Info

Publication number
AU3099600A
AU3099600A AU30996/00A AU3099600A AU3099600A AU 3099600 A AU3099600 A AU 3099600A AU 30996/00 A AU30996/00 A AU 30996/00A AU 3099600 A AU3099600 A AU 3099600A AU 3099600 A AU3099600 A AU 3099600A
Authority
AU
Australia
Prior art keywords
pharmaceutical agent
pharmaceutical
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30996/00A
Inventor
Leland Otto Weigel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3099600A publication Critical patent/AU3099600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU30996/00A 1998-12-07 1999-11-10 Pharmaceutical agent Abandoned AU3099600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11124398P 1998-12-07 1998-12-07
US60111243 1998-12-07
PCT/US1999/026809 WO2000034245A2 (en) 1998-12-07 1999-11-10 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase

Publications (1)

Publication Number Publication Date
AU3099600A true AU3099600A (en) 2000-06-26

Family

ID=22337361

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30996/00A Abandoned AU3099600A (en) 1998-12-07 1999-11-10 Pharmaceutical agent

Country Status (5)

Country Link
EP (1) EP1149080A2 (en)
JP (1) JP2002531550A (en)
AU (1) AU3099600A (en)
CA (1) CA2354022A1 (en)
WO (1) WO2000034245A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2169026T3 (en) * 1991-08-21 2002-07-01 Lilly Co Eli BENZO (F) QUINOLINONES AS INHIBITORS OF 5-ALFA-REDUCTASA.
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones

Also Published As

Publication number Publication date
EP1149080A2 (en) 2001-10-31
CA2354022A1 (en) 2000-06-15
JP2002531550A (en) 2002-09-24
WO2000034245A2 (en) 2000-06-15
WO2000034245A3 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1433299A (en) Disinfecting agent
AU5387898A (en) Pharmaceutical agents
AU6740298A (en) Pharmaceutical composition
AU1887401A (en) Medicinal composition
AU8107998A (en) Pharmaceutical compositions
AU1409100A (en) Drugs
AU2965199A (en) Medicine mini-chest
AU8591898A (en) Pharmaceutical compounds
AU3344099A (en) Analgetic agent
AU1554301A (en) Radioprotecting agent
AU9343098A (en) Pharmaceutical composition
AU1645700A (en) Oenothein medicaments
GB9818927D0 (en) Pharmaceutical formulation
AUPP332898A0 (en) Pharmaceutical composition
AU6480299A (en) Pharmaceutical compounds
AU1688099A (en) Pharmaceutical preparation
AU5182099A (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
AU5184599A (en) Pharmaceutical compounds
AU2279800A (en) Pharmaceutical preparation
AU5760999A (en) Antimycotic drug composition
AUPP574298A0 (en) Pharmaceutical preparation
AU3099600A (en) Pharmaceutical agent
AU3194197A (en) Stainblocking agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase